IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,961 | -98.2% | 75,259 | -98.9% | 0.00% | -100.0% |
| Q1 2023 | $165,753 | +59.8% | 6,812,646 | +40.7% | 0.02% | +47.1% |
| Q4 2022 | $103,703 | -99.8% | 4,843,659 | +40.5% | 0.02% | +70.0% |
| Q3 2022 | $61,829,000 | +89.6% | 3,446,354 | +1.7% | 0.01% | +150.0% |
| Q2 2022 | $32,613,000 | -58.0% | 3,390,140 | -26.5% | 0.00% | -50.0% |
| Q1 2022 | $77,591,000 | -8.0% | 4,610,276 | -8.6% | 0.01% | 0.0% |
| Q4 2021 | $84,374,000 | +4.3% | 5,046,287 | +1.3% | 0.01% | 0.0% |
| Q3 2021 | $80,865,000 | +524.3% | 4,979,398 | +142.6% | 0.01% | +700.0% |
| Q2 2021 | $12,953,000 | -3.1% | 2,052,740 | -5.1% | 0.00% | 0.0% |
| Q1 2021 | $13,369,000 | -10.2% | 2,163,192 | +0.4% | 0.00% | -50.0% |
| Q4 2020 | $14,882,000 | +21.2% | 2,153,672 | -1.1% | 0.00% | +100.0% |
| Q3 2020 | $12,280,000 | -14.9% | 2,177,224 | -23.0% | 0.00% | -50.0% |
| Q2 2020 | $14,430,000 | – | 2,829,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |